Trump’s Drug Pricing Victories Are A Winning Issue — If Republicans Use Them

(Photo by Nathan Howard/Getty Images)

President Trump has delivered real results on drug pricing, and our new national survey of likely voters makes clear those results are a political asset Republicans cannot afford to ignore heading into the 2026 midterms. 

The survey — conducted March 10–14, 2026, among 2,000 likely voters, with a margin of error of /- 2.2% at a 95% confidence interval — reveals the scope of voters’ healthcare cost anxieties and the enormous political opportunity available to Republicans who move decisively to address them.

Start with the dominant concern: the cost of health insurance. Fifty-one percent (51%) of likely voters name it as their single biggest healthcare worry. Every other concern — hospital bills, drug costs, quality of care, access — is fragmented far behind. It is particularly acute among voters with private insurance, where 76% cite insurance costs as a top concern, and among seniors, where 71% do. These voters are not asking for sympathy. They are demanding action. (RELATED: Dems Who Clapped Like Seals For Biden’s Big Pharma Actions Do 180 On Trump Drug Pricing Order)

So what happens to a Republican candidate who supports President Trump’s call to end taxpayer subsidies for big insurance companies, and instead send that money directly to........

© The Daily Caller